156 related articles for article (PubMed ID: 21906168)
1. A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease.
Wendland EM; Kaplan AA
Semin Dial; 2012; 25(1):82-5. PubMed ID: 21906168
[TBL] [Abstract][Full Text] [Related]
2. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Hecking M; Karaboyas A; Saran R; Sen A; Hörl WH; Pisoni RL; Robinson BM; Sunder-Plassmann G; Port FK
Am J Kidney Dis; 2012 Feb; 59(2):238-48. PubMed ID: 21944663
[TBL] [Abstract][Full Text] [Related]
3. Successful management of severe hyponatremia in CKD-VD: In a cost limited setting.
Pattanashetti N; Bharati J; Kohli HS; Gupta KL; Ramachandran R
Hemodial Int; 2019 Apr; 23(2):E69-E71. PubMed ID: 30773820
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysis.
Bender FH
Am J Kidney Dis; 1998 Nov; 32(5):829-31. PubMed ID: 9820455
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of extreme hyponatremia in an anuric patient using continuous venovenous hemodialysis.
Viktorsdottir O; Indridason OS; Palsson R
Blood Purif; 2013; 36(3-4):274-9. PubMed ID: 24496199
[TBL] [Abstract][Full Text] [Related]
7. A standard hemodialysis prescription to prevent osmotic demyelination in hyponatremic patients requiring dialysis.
Koc NS; Yildirim T; Girgin S; Onal C; Tahillioglu Y; Yilmaz R; Arici M; Altun B; Erdem Y
Ther Apher Dial; 2022 Dec; 26(6):1182-1186. PubMed ID: 35199958
[TBL] [Abstract][Full Text] [Related]
8. Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease.
Aybal Kutlugün A; Erdem Y; Okutucu S; Yorgun H; Atalar E; Arici M
Nephrol Dial Transplant; 2011 Nov; 26(11):3678-82. PubMed ID: 21421595
[TBL] [Abstract][Full Text] [Related]
9. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.
Song JH; Park GH; Lee SY; Lee SW; Lee SW; Kim MJ
J Am Soc Nephrol; 2005 Jan; 16(1):237-46. PubMed ID: 15563561
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid.
Yessayan L; Yee J; Frinak S; Szamosfalvi B
Am J Kidney Dis; 2014 Aug; 64(2):305-10. PubMed ID: 24792353
[TBL] [Abstract][Full Text] [Related]
11. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain.
Tarhan NC; Agildere AM; Benli US; Ozdemir FN; Aytekin C; Can U
AJR Am J Roentgenol; 2004 Mar; 182(3):809-16. PubMed ID: 14975990
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia and hypokalemia in patients on peritoneal dialysis.
Zanger R
Semin Dial; 2010; 23(6):575-80. PubMed ID: 21121953
[TBL] [Abstract][Full Text] [Related]
13. Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient.
Huang WY; Weng WC; Peng TI; Ro LS; Yang CW; Chen KH
Ren Fail; 2007; 29(5):635-8. PubMed ID: 17654329
[TBL] [Abstract][Full Text] [Related]
14. The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis.
Po CL; Afolabi M; Raja RM
ASAIO J; 1993; 39(3):M798-800. PubMed ID: 8268648
[TBL] [Abstract][Full Text] [Related]
15. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database).
Baldasseroni S; Urso R; Orso F; Bianchini BP; Carbonieri E; Cirò A; Gonzini L; Leonardi G; Marchionni N; Maggioni AP;
J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):723-31. PubMed ID: 21873881
[TBL] [Abstract][Full Text] [Related]
16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
17. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
Manlucu J; Gallo K; Heidenheim PA; Lindsay RM
Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632
[TBL] [Abstract][Full Text] [Related]
18. Individualized reduction in dialysate sodium in conventional in-center hemodialysis.
Arramreddy R; Sun SJ; Munoz Mendoza J; Chertow GM; Schiller B
Hemodial Int; 2012 Oct; 16(4):473-80. PubMed ID: 22554224
[TBL] [Abstract][Full Text] [Related]
19. Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.
Munoz Mendoza J; Arramreddy R; Schiller B
Am J Kidney Dis; 2015 Oct; 66(4):710-20. PubMed ID: 25987259
[TBL] [Abstract][Full Text] [Related]
20. Dialysate sodium, serum sodium and mortality in maintenance hemodialysis.
Mc Causland FR; Brunelli SM; Waikar SS
Nephrol Dial Transplant; 2012 Apr; 27(4):1613-8. PubMed ID: 21891777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
